Cytosorbents Corporation (CTSO)
USD 0.86
(5.91%)
USD 0.86
(5.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -21.65 Million | -28.23 Million | -14 Million | -5.61 Million | -16.75 Million | -10.83 Million |
| Net Income | -28.5 Million | -32.81 Million | -24.55 Million | -7.83 Million | -19.26 Million | -17.21 Million |
| Depreciation & Amortization | 2.02 Million | 1.13 Million | 1.12 Million | 660.78 Thousand | 581.53 Thousand | 390.55 Thousand |
| Deferred income taxes | -1256.92 Billion | - | - | -2.7 Million | 422.79 Thousand | 799.51 Thousand |
| Stock-based compensation | 3.7 Million | 3.8 Million | 6.2 Million | 4.7 Million | 2.83 Million | - |
| Change in working capital | 2.36 Million | -3.56 Million | 641.89 Thousand | -757.86 Thousand | -1.45 Million | -937.77 Thousand |
| Other non-cash items | 1256.92 Billion | 3.2 Million | 2.57 Million | 322.81 Thousand | 115.2 Thousand | 734.04 Thousand |
| Investing Cash Flow | -936.23 Thousand | -6.45 Million | -4.28 Million | -1.67 Million | -1.52 Million | -1.52 Million |
| Investments in PPE | -936.23 Thousand | -6.45 Million | -4.28 Million | -1.67 Million | -1.52 Million | -1.52 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -398.12 Thousand | -368.21 Thousand | -640.01 Thousand | -967.82 Thousand | -821.95 Thousand | - |
| Financing Cash Flow | 14.47 Million | 4.95 Million | 715.19 Thousand | 66.34 Million | 8.17 Million | 17.46 Million |
| Debt repayment | - | -5 Million | - | -16.41 Million | -4.99 Million | -666.66 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -40.35 Thousand | -90 Thousand | - | - | - |
| Common Stock Issuance | 14.47 Million | -40.35 Thousand | 715.19 Thousand | 80.21 Million | 673.65 Thousand | 14.12 Million |
| Other Financing Activities | 14.47 Million | -40.35 Thousand | 90 Thousand | 2.54 Million | 12.49 Million | 4 Million |
| Accounts receivables | -245.61 Thousand | -1.28 Million | 420.57 Thousand | -326.86 Thousand | -642.17 Thousand | -1.84 Million |
| Accounts payables | 1.62 Million | -3248.97 Billion | 2.42 Million | 1424.44 Billion | 470.55 Thousand | 1.7 Million |
| Inventory | -121.03 Thousand | 945.35 Thousand | -2.35 Million | -461.51 Thousand | -1.28 Million | -56.75 Thousand |
| Other working capital | 1.1 Million | 3248.97 Billion | 145.05 Thousand | -1424.43 Billion | 4030.00 | -738.01 Thousand |
| Cash at beginning of period | 22.14 Million | 53.82 Million | 71.42 Million | 12.23 Million | 22.36 Million | 17.32 Million |
| Cash at end of period | 14.13 Million | 23.83 Million | 53.82 Million | 71.42 Million | 12.23 Million | 22.36 Million |
| Capital Expenditure | -936.23 Thousand | -6.45 Million | -4.28 Million | -1.67 Million | -1.52 Million | -1.52 Million |
| Effect of forex changes on cash | -99.76 Thousand | -262.92 Thousand | -24.77 Thousand | 130.35 Thousand | -35.19 Thousand | -58.93 Thousand |
| Net cash flow / Change in cash | -8.01 Million | -29.99 Million | -17.59 Million | 59.18 Million | -10.13 Million | 5.04 Million |
| Free Cash Flow | -22.59 Million | -34.68 Million | -18.28 Million | -7.28 Million | -18.27 Million | -12.35 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.14 Million | -6.35 Million | -5.83 Million | -28.5 Million | -9.19 Million | -6.15 Million |
| Depreciation & Amortization | 446.51 Thousand | 443.21 Thousand | 792.67 Thousand | 2.02 Million | 462.64 Thousand | 457.4 Thousand |
| Deferred income taxes | - | - | -2.29 Million | -1256.92 Billion | 1.99 Million | -231.89 Thousand |
| Stock-based compensation | 837.58 Thousand | 924.3 Thousand | 1.05 Million | 3.7 Million | 1.35 Million | 214.54 Thousand |
| Change in working capital | -2.76 Million | -1.36 Million | 74.29 Thousand | 2.36 Million | 167.73 Thousand | -1.23 Million |
| Other non-cash items | 5.01 Million | 5.59 Million | -194.81 Thousand | 1256.92 Billion | 10.71 Thousand | 10.71 Thousand |
| Investing Cash Flow | -119.86 Thousand | -127.01 Thousand | -135.92 Thousand | -936.23 Thousand | -257.71 Thousand | 140.28 Thousand |
| Investments in PPE | -119.86 Thousand | -127.01 Thousand | -135.92 Thousand | -936.23 Thousand | -257.71 Thousand | 209.44 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -101.63 Thousand | -81.82 Thousand | -40.42 Thousand | -398.12 Thousand | -115.31 Thousand | -69.16 Thousand |
| Financing Cash Flow | 9.83 Million | -571.76 Thousand | 12.21 Million | 14.47 Million | 648.32 Thousand | 931.11 Thousand |
| Debt repayment | -9.98 Million | -625 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 12.00 | 53.23 Thousand | 12.21 Million | 14.47 Million | 845.7 Thousand | 776.28 Thousand |
| Other Financing Activities | -150 Thousand | 53.23 Thousand | 12.21 Million | 14.47 Million | 648.32 Thousand | 931.11 Thousand |
| Accounts receivables | -1.1 Million | -848.33 Thousand | 357.67 Thousand | -245.61 Thousand | 668.43 Thousand | -1.44 Million |
| Accounts payables | -750.29 Thousand | -1.28 Million | 575.88 Thousand | 1.62 Million | 756.63 Thousand | -338.81 Thousand |
| Inventory | -600.43 Thousand | -125.55 Thousand | -592.86 Thousand | -121.03 Thousand | -978.05 Thousand | -297.26 Thousand |
| Other working capital | -310.95 Thousand | 886.25 Thousand | -266.39 Thousand | 1.1 Million | -279.26 Thousand | 854 Thousand |
| Cash at beginning of period | 8.6 Million | 14.13 Million | 8.35 Million | 22.14 Million | 14.83 Million | 20.73 Million |
| Cash at end of period | 8.45 Million | 8.6 Million | 14.13 Million | 14.13 Million | 10.04 Million | 14.83 Million |
| Capital Expenditure | -119.86 Thousand | -127.01 Thousand | -135.92 Thousand | -936.23 Thousand | -257.71 Thousand | 209.44 Thousand |
| Effect of forex changes on cash | -69.79 Thousand | 5782.00 | -98.56 Thousand | -99.76 Thousand | 23.14 Thousand | -35 Thousand |
| Net cash flow / Change in cash | -149.67 Thousand | -5.52 Million | 5.77 Million | -8.01 Million | -4.79 Million | -5.89 Million |
| Free Cash Flow | -4.91 Million | -4.95 Million | -6.54 Million | -22.59 Million | -5.46 Million | -6.72 Million |
GVFF
007980
TATT
AIROLAM
ALOD
OSM